Gene · 259
Papers2,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Candidate protein biomarkers in chronic kidney disease: a proteomics study. | Sci Rep | 2024 | 38890379 | PubTator, text mining | PubMed |
| Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies. | Kidney Med | 2024 | 38826568 | PubTator, text mining | PubMed |
| iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus. | Lupus Sci Med | 2024 | 38782493 | PubTator, text mining | PubMed |
| Therapeutic α-1-microglobulin ameliorates kidney ischemia-reperfusion injury. | Am J Physiol Renal Physiol | 2024 | 38779750 | PubTator, text mining | PubMed |
| Major endothelial damage markers identified from hemadsorption filters derived from treated patients with septic shock - endoplasmic reticulum stress and bikunin may play a role. | Front Immunol | 2024 | 38698864 | PubTator, text mining | PubMed |
| Structure, Functions, and Implications of Selected Lipocalins in Human Disease. | Int J Mol Sci | 2024 | 38673873 | PubTator, text mining | PubMed |
| A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes. | J Proteomics | 2024 | 38574989 | PubTator, text mining | PubMed |
| Defining the mechanisms and properties of post-transcriptional regulatory disordered regions by high-throughput functional profiling. | bioRxiv | 2024 | 38370681 | PubTator, text mining | PubMed |
| Application of Raman spectroscopy during pharmaceutical process development for determination of critical quality attributes in Protein A chromatography. | J Chromatogr A | 2024 | 38341902 | PubTator, text mining | PubMed |
| Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics. | iScience | 2024 | 38303703 | PubTator, text mining | PubMed |
| Characterization of T cell receptor repertoire in penile cancer. | Cancer Immunol Immunother | 2024 | 38280010 | PubTator, text mining | PubMed |
| Comparative and integrative single cell analysis reveals new insights into the transcriptional immaturity of stem cell-derived β cells. | BMC Genomics | 2024 | 38267908 | PubTator, text mining | PubMed |
| Proteomic Profiling Identifies Candidate Diagnostic Biomarkers of Hydrosalpinx in Endometrial Fluid: A Pilot Study. | Int J Mol Sci | 2024 | 38256043 | PubTator, text mining | PubMed |
| Toward Precision Medicine: Exploring the Landscape of Biomarkers in Acute Kidney Injury. | Biomolecules | 2024 | 38254682 | PubTator, text mining | PubMed |
| Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response. | Metabolites | 2024 | 38248854 | PubTator, text mining | PubMed |
| The effector program of human CD8 T cells supports tissue remodeling. | J Exp Med | 2024 | 38226976 | PubTator, text mining | PubMed |
| Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV. | AIDS | 2024 | 38224361 | PubTator, text mining | PubMed |
Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV). | Trials | 2024 | 38212836 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles. | Nat Aging | 2024 | 38195725 | PubTator, text mining | PubMed |
| Red blood cell-derived arginase release in hemolytic uremic syndrome. | J Transl Med | 2024 | 38178089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259/papers?page=5